Benjamin F. Chu

653 total citations
8 papers, 517 citations indexed

About

Benjamin F. Chu is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Benjamin F. Chu has authored 8 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Neurology. Recurrent topics in Benjamin F. Chu's work include Drug Transport and Resistance Mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Benjamin F. Chu is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Benjamin F. Chu collaborates with scholars based in United States, Hong Kong and Hungary. Benjamin F. Chu's co-authors include Joseph A. Ludwig, Henry M. Fales, Gergely Szakács, Gregory A. Otterson, Michael M. Gottesman, Suresh V. Ambudkar, Zuben E. Sauna, John N. Weinstein, Natasha J. Caplen and Carol Cardarelli and has published in prestigious journals such as Blood, Cancer Research and American Journal of Roentgenology.

In The Last Decade

Benjamin F. Chu

8 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin F. Chu United States 8 241 209 84 68 62 8 517
L‐M Ching New Zealand 11 147 0.6× 254 1.2× 29 0.3× 52 0.8× 53 0.9× 11 532
C.J. Bol Netherlands 8 391 1.6× 271 1.3× 46 0.5× 61 0.9× 87 1.4× 10 557
Katherine Lu United States 13 273 1.1× 238 1.1× 107 1.3× 42 0.6× 102 1.6× 38 555
Hiromi Tanii Japan 12 269 1.1× 340 1.6× 57 0.7× 62 0.9× 57 0.9× 19 536
S. Murray Yule United Kingdom 16 233 1.0× 266 1.3× 64 0.8× 117 1.7× 89 1.4× 21 784
Greta Cipriani Italy 7 325 1.3× 166 0.8× 69 0.8× 91 1.3× 87 1.4× 7 529
Sandeep Batra United States 10 134 0.6× 274 1.3× 107 1.3× 170 2.5× 64 1.0× 38 689
Ronald Drengler United States 13 487 2.0× 296 1.4× 56 0.7× 16 0.2× 104 1.7× 27 701
Seng Chuan Tang Netherlands 12 380 1.6× 244 1.2× 71 0.8× 39 0.6× 148 2.4× 15 582
J. H. M. Schellens Netherlands 12 281 1.2× 156 0.7× 22 0.3× 29 0.4× 83 1.3× 18 506

Countries citing papers authored by Benjamin F. Chu

Since Specialization
Citations

This map shows the geographic impact of Benjamin F. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin F. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin F. Chu more than expected).

Fields of papers citing papers by Benjamin F. Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin F. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin F. Chu. The network helps show where Benjamin F. Chu may publish in the future.

Co-authorship network of co-authors of Benjamin F. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin F. Chu. A scholar is included among the top collaborators of Benjamin F. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin F. Chu. Benjamin F. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Owen, Dwight H., Benjamin F. Chu, Amy M. Lehman, et al.. (2018). Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma. Journal of Thoracic Oncology. 13(8). 1204–1212. 51 indexed citations
2.
Chu, Benjamin F. & Gregory A. Otterson. (2016). Incorporation of Antiangiogenic Therapy Into the Non–Small-Cell Lung Cancer Paradigm. Clinical Lung Cancer. 17(6). 493–506. 8 indexed citations
3.
Chu, Benjamin F., Weiqiang Zhao, Vedat Yildiz, et al.. (2015). CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. American Journal of Roentgenology. 205(5). 1016–1025. 63 indexed citations
4.
Chu, Benjamin F., Arwa Shana’ah, Craig C. Hofmeister, Don Benson, & Yvonne A. Efebera. (2014). Long Term Therapy with Lenalidomide in a patient with POEMS Syndrome. European Journal of Case Reports in Internal Medicine. 1(1). 7 indexed citations
5.
Chu, Benjamin F., Zhengyu Liu, Josephine Aimiuwu, et al.. (2012). Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 71(1). 115–121. 72 indexed citations
6.
Farrell, John J., Richard Sherva, Zhiyi Chen, et al.. (2011). A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood. 117(18). 4935–4945. 80 indexed citations
7.
Türk, Dóra, Matthew D. Hall, Benjamin F. Chu, et al.. (2009). Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells. Cancer Research. 69(21). 8293–8301. 87 indexed citations
8.
Ludwig, Joseph A., Gergely Szakács, Scott E. Martin, et al.. (2006). Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer. Cancer Research. 66(9). 4808–4815. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026